Infection Control News

There were increases in rare pediatric intracranial infections over the past 3 years that coincided with notable spikes in respiratory viruses, although the infections remained rare, according to two reports published Thursday in MMWR.

A recent study of trends in HPV vaccine hesitancy found that the number of parents citing safety concerns as a reason not to vaccinate their children has increased.

Researchers found that patients hospitalized withCOVID-19 received antibiotics for potential secondary bacterial infections without clinical indications suggesting they could benefit from the treatment.

The FDA has fully approved Paxlovid to treat COVID-19 in adults after the antiviral pill was first granted emergency use authorization in December 2021.

Incidence of myocarditis/pericarditis among veterans was low across more than 10 million doses of messenger RNA COVID-19 vaccines, given as a primary or booster dose, administered at the Veterans Health Administration, researchers found.

A pentavalent vaccine against Neisseria meningitidis was shown to be safe and effective in a phase 3 trial conducted among children and young adults in Africa’s meningitis belt, researchers reported in The New England Journal of Medicine.

Researchers created a symptom-based scoring system that may help diagnose long COVID more easily. The scoring system is based on 12 common symptoms identified in a study that included almost 10,000 participants.

The FDA on Thursday granted full approval for Paxlovid, making it the first oral antiviral pill approved by the FDA to treat COVID-19 in adults.

Gavi, the Vaccine Alliance forecasted that the global supply of oral cholera vaccine is likely to remain limited through 2025 if current outbreak trends continue.

The FDA has approved IV sulbactam-durlobactam to treat hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible strains of Acinetobacter baumannii-calcoaceticus complex.